INO Health & Biotech Stock Guide
BIOTECH, HEALTH & PHARMA NEWS
Myan’s CEO is grilled by congressional leaders on Capitol Hill, Allergan (NYSE:AGN) and Johnson & Johnson (NYSE:JNJ) step up merger and acquisition activity and the presidential debates are underway. Mylan has dominated the pharma news headlines recently over its aggressive pricing increases regarding its EpiPen which uses an auto-injection of epinephrine to treat severe allergic reactions, particularly deadly in school age children. Since Mylan acquired the product in 2007, and the “list” price increased from $100 in 2008 to its current “list” price of ~$600. Elijah Cummings Continue reading "Preview Issue #3 - Pharma Acquisitions Change The Game"